EIF2A 抗体 (AA 448-576)
-
- 抗原 See all EIF2A 抗体
- EIF2A (Eukaryotic Translation Initiation Factor 2A, 65kDa (EIF2A))
-
抗原表位
- AA 448-576
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This EIF2A antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
- 原理
- EIF2A Antibody
- 纯化方法
- Purified antibody
- 免疫原
- Purified recombinant fragment of human EIF2A (AA: 448-576) expressed in E. Coli.
- 克隆位点
- 3A7A8
- 亚型
- IgG1
- Top Product
- Discover our top product EIF2A Primary Antibody
-
-
- 应用备注
-
ELISA: 1/10000
FCM: 1/200 - 1/400
ICC: 1/200 - 1/1000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Purified antibody in PBS with 0.05 % sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells." in: Molekuliarnaia biologiia, Vol. 44, Issue 5, pp. 859-66, (2010) (PubMed).
: "Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy." in: Cancer research, Vol. 69, Issue 4, pp. 1545-52, (2009) (PubMed).
: "
-
Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells." in: Molekuliarnaia biologiia, Vol. 44, Issue 5, pp. 859-66, (2010) (PubMed).
-
- 抗原
- EIF2A (Eukaryotic Translation Initiation Factor 2A, 65kDa (EIF2A))
- 别名
- EIF2A (EIF2A 产品)
- 背景
-
Description: EIF2A is a 65-kD protein that catalyzes the formation of puromycin-sensitive 80S preinitiation complexes
Aliases: CDA02, EIF-2A, MST089, MSTP004, MSTP089
- 分子量
- 65kDa
- 基因ID
- 83939
- HGNC
- 83939
- UniProt
- Q9BY44
- 途径
- Ribonucleoprotein Complex Subunit Organization, ER-Nucleus Signaling, Hepatitis C, Methionine Biosynthetic Process, Ribosome Assembly
-